According to another report, the administration of apigenin could reduce the serum levels of TNF-a, IL-1b, IL-6 and the number of foam cells and at the same time reduce the associated inflammation and prevent atherosclerosis (Wang et al., 2015 ▶). This evidence concerns the gene IL1B and atherosclerosis.